Author

N. J. Kingston

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

N. J. Stonehouse· 3 shared D. J. Rowlands· 2 shared J. S. Snowden· 2 shared K. Grehan· 2 shared A. J. Macadam· 1 shared A. Martyna· 1 shared A. Roe· 1 shared A. Tedcastle· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

N. J. Stonehouse

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologyChemMedChemPeer-reviewedMar 10, 2023

Development of Enterovirus anti-viral agents that target the viral 2C protein

R. Kejriwal, T. Evans, J. Calabrese…·S. White

This study develops broad-spectrum anti-viral compounds targeting the conserved EV 2C protein, showing low IC50 values and suggesting a role for 2C in capsid assembly.

DOI 10.1002/cmdc.202200541

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintJan 30, 2023

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate.

N. J. Kingston, J. S. Snowden, A. Martyna…·N. J. Stonehouse

This study produces antigenically stable EVA71 virus-like particles in Pichia pastoris, showing they retain native antigenic conformation and elicit neutralising antibodies comparable to inactivated virus vaccines.

DOI 10.1101/2023.01.30.526315

experimental assaydrug response / drug discovery

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 22, 2022

VelcroVax: a bolt-on vaccine platform technology improves antibody titres against a viral glycoprotein in mice

N. J. Stonehouse, N. J. Kingston, K. Grehan…·D. J. Rowlands

VelcroVax is a vaccine platform that enhances antibody titres against a viral glycoprotein in mice by combining a modified VLP with a SUMO-tagged antigen.

DOI 10.1101/2022.04.22.489148

mouseproteomics

𝕏 PostBluesky